Analysis Plan
Section 1
Introduction
Pragmatic clinical trial designs, particularly those that use cluster randomization or other novel methods, pose challenges during the study design phase (Cook et al 2016). Here, we briefly examine current challenges in the design of pragmatic trials, as well as potential solutions and future directions for further exploration.
SECTIONS
CHAPTER SECTIONS
sections
- Introduction
- Intraclass Correlation
- Unequal Cluster Sizes
- Accounting for Residual Confounding in the Analysis
- Missing Data and Intention-to-Treat Analyses
- Electronic Health Record Data Extraction
- Unanticipated Changes
- Interim Reassessment of Sample Size in Cluster Randomized Trials
- Case Study: STOP CRC Trial
REFERENCES
Cook AJ, Delong E, Murray DM, Vollmer WM, Heagerty PJ. 2016. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core. Clin Trials. 13:504-512. doi:10.1177/1740774516646578. PMID: 27179253.
current section : Introduction
- Introduction
- Intraclass Correlation
- Unequal Cluster Sizes
- Accounting for Residual Confounding in the Analysis
- Missing Data and Intention-to-Treat Analyses
- Electronic Health Record Data Extraction
- Unanticipated Changes
- Interim Reassessment of Sample Size in Cluster Randomized Trials
- Case Study: STOP CRC Trial